Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

Delayed Data
As of Apr 24
 +0.04 / +1.51%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Sunesis Pharmaceuticals Inc have a median target of 3.50, with a high estimate of 5.50 and a low estimate of 1.50. The median estimate represents a +30.11% increase from the last price of 2.69.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Sunesis Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -678.55%
Growthannually 20.57%


Growthquarterly 9.04%
Growthannually -37.75%
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account